Line 240: | Line 240: | ||
<a href="#BBa_K2372004">BBa_K2372004 </a> <br> | <a href="#BBa_K2372004">BBa_K2372004 </a> <br> | ||
− | + | <a href="#BBa_K2372000">BBa_K2372000 </a> <br> | |
+ | <a href="#BBa_K2372001">BBa_K2372001 </a> <br> | ||
+ | <a href="#BBa_K2372002">BBa_K2372002 </a> <br> | ||
+ | <a href="#BBa_K2372003">BBa_K2372003 </a> <br> | ||
+ | <a href="#BBa_K2372005">BBa_K2372005 </a> <br> | ||
+ | <a href="#BBa_K2372006">BBa_K2372006 </a> <br> | ||
+ | |||
</nav> | </nav> | ||
Line 251: | Line 257: | ||
<div id="Fliesstext1"> | <div id="Fliesstext1"> | ||
<h1 id="Basic Parts">Basic Parts</h1> | <h1 id="Basic Parts">Basic Parts</h1> | ||
+ | |||
+ | |||
<h2 id="BBa_K2372004" class="anchor">BBa_K2372004</h2> | <h2 id="BBa_K2372004" class="anchor">BBa_K2372004</h2> | ||
Line 257: | Line 265: | ||
<p> <strong> <a href="http://parts.igem.org/Part:BBa_K2372004">BBa_K2372004</a> </strong> </p> | <p> <strong> <a href="http://parts.igem.org/Part:BBa_K2372004">BBa_K2372004</a> </strong> </p> | ||
− | <h2 id="" class="anchor"></h2> | + | |
+ | <h2 id="BBa_K2372000" class="anchor">BBa_K2372000</h2> | ||
+ | |||
+ | <p> CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics | ||
+ | </p> | ||
+ | |||
+ | <p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372000">BBa_K2372000</a> </strong> </p> | ||
+ | |||
+ | |||
+ | <h2 id="BBa_K2372001" class="anchor">BBa_K2372001</h2> | ||
+ | |||
+ | <p> CloL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics | ||
+ | </p> | ||
+ | |||
+ | <p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372001">BBa_K2372001</a> </strong> </p> | ||
+ | |||
+ | |||
+ | <h2 id="BBa_K2372002" class="anchor">BBa_K2372002</h2> | ||
+ | |||
+ | <p> β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid | ||
+ | </p> | ||
+ | |||
+ | <p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372002">BBa_K2372002</a> </strong> </p> | ||
+ | |||
+ | |||
+ | |||
+ | <h2 id="BBa_K2372003" class="anchor">BBa_K2372003</h2> | ||
+ | |||
+ | <p> The BLS mutant is a rationally designed mutant of the β-lactam synthetase | ||
+ | </p> | ||
+ | |||
+ | <p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372003">BBa_K2372003</a> </strong> </p> | ||
+ | |||
+ | |||
+ | <h2 id="BBa_K2372005" class="anchor">BBa_K2372005</h2> | ||
+ | |||
+ | <p> Gyrase B (GyrB)is a type II topoisomerase | ||
+ | </p> | ||
+ | |||
+ | <p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372005">BBa_K2372005</a> </strong> </p> | ||
+ | |||
+ | |||
+ | <h2 id="BBa_K2372006" class="anchor">BBa_K2372006</h2> | ||
+ | |||
+ | <p> Gyrase B (GyrB)is a type II topoisomerase | ||
+ | </p> | ||
+ | |||
+ | <p> <strong> <a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K2372006">BBa_K2372006</a> </strong> </p> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
Revision as of 22:43, 1 November 2017
Basic Parts
BBa_K2372004
SHV-1 is a β-lactamase that mediates resistance against ꞵ-lactams
BBa_K2372000
CouL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
BBa_K2372001
CloL is a amide synthetase that catalyzes the bonding of the amide bonds in aminocoumarin antibiotics
BBa_K2372002
β-lactam synthetase (BLS) catalyzes the formation of the β-lactam ring of clavulanic acid
BBa_K2372003
The BLS mutant is a rationally designed mutant of the β-lactam synthetase
BBa_K2372005
Gyrase B (GyrB)is a type II topoisomerase
BBa_K2372006
Gyrase B (GyrB)is a type II topoisomerase